From the Journals

Axial SpA disease activity remains mostly stable throughout pregnancy

Publish date: March 23, 2018

 

FROM RHEUMATOLOGY

SOURCE: Ursin K et al. Rheumatology. 2018 Mar 14. doi: 10.1093/rheumatology/key047.

Pages

Recommended Reading

ACR: Etanercept during pregnancy doubles the odds of major malformations
MDedge ObGyn
Biologic treatment in pregnancy requires balancing risks
MDedge ObGyn
New CDC opioid guideline targets overprescribing for chronic pain
MDedge ObGyn
PIANO study provides insight on safety of biologics in pregnancy
MDedge ObGyn
Psoriasis cardiovascular risk parallels type 2 diabetes
MDedge ObGyn
Study offers reassuring data on certolizumab use in pregnancy
MDedge ObGyn
Breast milk doesn’t contain meaningful levels of certolizumab pegol
MDedge ObGyn
Stopping TNF inhibitors for pregnancy may invite flares
MDedge ObGyn
Maternal biologic therapy does not affect infant vaccine responses
MDedge ObGyn
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge ObGyn

Related Articles